[Blood thromboxane A2 and prostaglandin I2 levels and platelet phospholipid fatty acid composition ratios in ischemic heart disease and cerebral infarction--with special reference to the effect of antiplatelet agents].
D000368:Aged; D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000032:analysis* / Q000187:drug effects; D002544:Cerebral Infarction / Q000097:blood*; D003327:Coronary Disease / Q000097:blood*; D004176:Dipyridamole / Q000494:pharmacology; D011464:Epoprostenol / Q000097:blood*; D005227:Fatty Acids / Q000097:blood; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010743:Phospholipids / Q000097:blood; D013928:Thromboxane A2 / Q000097:blood*; D013931:Thromboxanes / Q000097:blood*; D014192:Trapidil / Q000494:pharmacology
D005227:Fatty Acids; D010743:Phospholipids; D013931:Thromboxanes; D013928:Thromboxane A2; D004176:Dipyridamole; D011464:Epoprostenol; D014192:Trapidil; D001241:Aspirin